Kenneth Sadowsky, who serves on the board of The Vita Coco Company, Inc. (NASDAQ: COCO), executed a sale of 3,900 shares of the company's common stock on April 15, 2026, generating proceeds of approximately $190,827. The shares changed hands at prices between $48.50 and $49.34 per share. The transaction was completed through a pre-arranged Rule 10b5-1 trading plan.
After the sale, Sadowsky's direct ownership stands at 586,566 shares of Vita Coco common stock. In addition to his shareholdings, he holds options to acquire 27,300 shares at an exercise price of $10.178 per share. Those options are fully vested, currently exercisable, and carry an expiration date of January 2, 2030.
The timing of the insider sale arrives against a backdrop of notable stock performance and recent analyst activity. Vita Coco's shares have delivered a 61% gain over the past year, although the stock has softened in the near term and is trading above InvestingPro's Fair Value estimate, a status that places the security on InvestingPro's Most Overvalued list.
Analyst sentiment has shown pockets of heightened optimism. Evercore ISI maintained an Outperform rating on the company and raised its price target from $58 to $70, citing robust sales growth and a favorable outlook for fiscal year 2026. Evercore ISI called out a 51.1% increase in scanner data sales for the week ending March 8, attributing the jump to effective promotional strategies.
Separately, Morgan Stanley lifted its price target for Vita Coco to $57 from $49 while keeping an Equalweight rating. That adjustment coincided with Morgan Stanley increasing its fiscal 2026 and 2027 adjusted EBITDA estimates by 11% and 12%, respectively, revisions the firm made after Vita Coco reported fourth-quarter results in February.
Both Evercore ISI and Morgan Stanley expressed confidence in the company's longer-term growth prospects, with Evercore ISI notably more bullish in its outlook. Collectively, these analyst moves reflect a generally favorable tone toward Vita Coco's future performance while the stock's valuation signals have pushed it onto overvaluation lists maintained by InvestingPro.
Clear summary
Kenneth Sadowsky sold 3,900 shares of Vita Coco on April 15, 2026 under a Rule 10b5-1 plan for about $190,827; he retains 586,566 shares and 27,300 fully vested options exercisable at $10.178 through January 2, 2030. The sale coincides with a 61% year-over-year share gain, recent analyst target increases from Evercore ISI and Morgan Stanley, and a valuation assessment that places the stock above InvestingPro's Fair Value estimate.